Differences in primary care clinicians' approach to non-small cell lung cancer patients compared with breast cancer

Journal of Thoracic Oncology

Volumn 2, Issue 8, 2007, Pages 722-728

  Wassenaar, Timothy R ^a   Eickhoff, Jens C ^a   Jarzemsky, Daniel R ^a   Smith, Stevens S ^a   Larson, Marilyn L ^a   Schiller, Joan H ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Non small cell lung cancer; Primary care; Quality of care

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL COMPETENCE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION;

EID: 34548391398     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3180cc2599     Document Type: Article

References (18)

1. American Cancer Society. Cancer Facts and Figures 2006. Atlanta: American Cancer Society, 2006.
2. Brown L, Macintyre K, Trujillo L. Interventions to reduce HIV/AIDS stigma: what have we learned? AIDS Educ Prev 2003;15:49-69.
3. Mandru N. Stigma and HIV: does the social response affect the natural course of the epidemic? J Assoc Nurses AIDS Care 2003;14:39-48.
4. Woodhead K. Fighting AIDS stigma. Caring for all. Br J Perioper Nurs 2003;13:255-261.
5. Jambekar S, Masheb R, Grilo C. Gender differences in shame in patients with binge-eating disorder. Obes Res 2003;11:571-577.
6. Sanftner J, Crowther J. Variability in self-esteem, moods, shame, and guilt in women who binge. Int J Eat Disord 1998;23:391-397.
7. Chapple A, Ziebland S, McPherson A. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. BMJ 2004;328:1470.
8. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-2597.
9. Strauss G, Herndon J, Maddaus M, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage Ib non-small cell lung cancer (NSCLC): report of cancer and leukemia group b (calgb) protocol 9633 [abstract]. Proc Annu Meet Am Assoc Cancer Res 2004;22 (14 suppl):7019.
10. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346:92-98.
11. Piga A, Graziano F, Zahra G, et al. Attitudes of non-oncology physicians dealing with cancer patients. A survey based on clinical scenarios in Ancona, central Italy. Tumori 1996;82:423-429.
12. Gennari A, Conte P, Rosso R, et al. Survival of metastatic breast carcinoma patients over a 20 year period. Cancer 2005;104:1742-1750.
13. Douillard J, Rosell R, Delena M, et al. ANITA: phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association [abstract]. Proc Annu Meet Am Assoc Cancer Res 2005;23(16 suppl):7013.
14. Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004;350:1713-1721.
15. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360.
16. Sandler A, Gray R, Brahmer J, et al. Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC # 704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): an Eastern Cooperative Oncology Group (ECOG) Trial - E4599 [abstract]. Proc Annu Meet Am Assoc Cancer Res 2005;23(16 suppl):4.
17. Earle C, Neumann P, Gelber R, et al. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 2002;20:1786-1792.
18. Bigger M. The uses and limitations of survey methods within primary care practice. J Clin Nurs 2003;17:4-8.